Jiqun Pharmaceutical is an innovative pharmaceutical company that focuses on the research and development of new drugs. It provides one-stop services such as drug synthesis, drug analysis, preparation development, pharmacology and toxicology research, clinical research, drug consistency evaluation, and packaging material compatibility research. ability.
The company combines the latest progress in international new technologies, new materials and other fields to build a new drug development platform and engage in the research and development of innovative drugs and generic drugs.
The company is oriented to meet clinical needs and is committed to the research and development of innovative and improved new drugs in the fields of tumors, hepatitis B, severe infections and gynecology. According to the latest national drug registration classification principles, the innovative drugs selected for development include Category 1.1 First in Class/Best in Class; there are also exclusive patented products of fixed-dose combinations; there are also new preparations that are more suitable for clinical application, or modified salts, or new "Improved innovative" products for clinical use, etc. Rich products, reasonable layout, careful planning, and proper risk control!
At the same time, the company relies on the drug marketing authorization holder system to select generic drugs with technical barriers for development. Through business models such as independent development, technology transfer, cooperative development, and entrusted development, the company integrates upstream and downstream industry resources to provide pharmaceutical companies and drug distribution companies. Provide high-quality project goals!